Co-evolution of drug resistance and broadened substrate recognition in HIV protease variants isolated from an Escherichia coli genetic selection system

Biochem J. 2022 Feb 17;479(4):479-501. doi: 10.1042/BCJ20210767.

Abstract

A genetic selection system for activity of HIV protease is described that is based on a synthetic substrate constructed as a modified AraC regulatory protein that when cleaved stimulate l-arabinose metabolism in an Escherichia coli araC strain. Growth stimulation on selective plates was shown to depend on active HIV protease and the scissile bond in the substrate. In addition, the growth of cells correlated well with the established cleavage efficiency of the sites in the viral polyprotein, Gag, when these sites were individually introduced into the synthetic substrate of the selection system. Plasmids encoding protease variants selected based on stimulation of cell growth in the presence of saquinavir or cleavage of a site not cleaved by wild-type protease, were indistinguishable with respect to both phenotypes. Also, both groups of selected plasmids encoded side chain substitutions known from clinical isolates or displayed different side chain substitutions but at identical positions. One highly frequent side chain substitution, E34V, not regarded as a major drug resistance substitution was found in variants obtained under both selective conditions and is suggested to improve protease processing of the synthetic substrate. This substitution is away from the substrate-binding cavity and together with other substitutions in the selected reading frames supports the previous suggestion of a substrate-binding site extended from the active site binding pocket itself.

Keywords: E coli genetic selection system; AraC protein; random mutagenesis analysis; retro viral protease; substrate recognition.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Substitution
  • Anti-HIV Agents / pharmacokinetics*
  • AraC Transcription Factor / genetics
  • Arabinose / metabolism
  • Chymosin / metabolism
  • Drug Resistance, Viral / genetics*
  • Escherichia coli
  • Escherichia coli Proteins / genetics
  • Fusion Proteins, gag-pol / metabolism
  • Gene Products, gag / metabolism
  • Genes, araC
  • HIV Protease / chemistry
  • HIV Protease / genetics*
  • HIV Protease / isolation & purification
  • HIV Protease / metabolism
  • Models, Molecular
  • Mutation, Missense
  • Point Mutation
  • Protein Conformation
  • Recombinant Fusion Proteins / genetics
  • Recombinant Fusion Proteins / metabolism
  • Saquinavir / antagonists & inhibitors
  • Saquinavir / pharmacology
  • Selection, Genetic
  • Sequence Alignment
  • Sequence Homology, Amino Acid
  • Structure-Activity Relationship
  • Substrate Specificity

Substances

  • Anti-HIV Agents
  • AraC Transcription Factor
  • AraC protein, E coli
  • Escherichia coli Proteins
  • Fusion Proteins, gag-pol
  • Gene Products, gag
  • Recombinant Fusion Proteins
  • Arabinose
  • HIV Protease
  • p16 protease, Human immunodeficiency virus 1
  • Chymosin
  • Saquinavir